Profound Medical (PRN) Set to Announce Earnings on Thursday

Profound Medical (TSE:PRN) will post its quarterly earnings results after the market closes on Thursday, May 9th. Analysts expect Profound Medical to post earnings of C($0.41) per share for the quarter.

Profound Medical (TSE:PRN) last announced its earnings results on Thursday, March 7th. The company reported C($0.57) earnings per share (EPS) for the quarter, missing the consensus estimate of C($0.38) by C($0.19). The company had revenue of C$2.74 million for the quarter, compared to the consensus estimate of C$2.56 million.

Profound Medical Stock Down 0.2 %

Shares of TSE:PRN opened at C$10.04 on Tuesday. Profound Medical has a 52-week low of C$9.55 and a 52-week high of C$20.44. The firm has a fifty day moving average of C$11.12 and a 200 day moving average of C$11.73. The firm has a market capitalization of C$16.67 million, a PE ratio of -5.49 and a beta of 1.24. The company has a debt-to-equity ratio of 25.47, a quick ratio of 14.98 and a current ratio of 6.58.

Profound Medical Company Profile

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum.